4.7 Article

Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 19, Issue 24, Pages 7603-7611

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2011.10.021

Keywords

TMPKmt; Thymidine analogues; alpha- and beta-Nucleosides; Spectrophotometric binding assay; Inhibitory activity

Funding

  1. BOF, Ghent University
  2. Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen)
  3. Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)
  4. Institut Pasteur (GPH Tuberculose, DAR-RI)
  5. CNRS
  6. INSERM

Ask authors/readers for more resources

We report on Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibitory activities of a series of new 3'- and 5'-modified thymidine analogues including alpha- and beta-derivatives. In addition, several analogues were synthesized in which the 4-oxygen was replaced by a more lipophilic sulfur atom to probe the influence of this modification on TMPKmt inhibitory activity. Several compounds showed an inhibitory potency in the low micromolar range, with the 5'-arylthiourea 4-thio-alpha-thymidine analogue being the most active one (K(i) = 0.17 mu M). This compound was capable of inhibiting mycobacteria growth at a concentration of 25 mu g/mL. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available